B. Riley Expects Lower Earnings for Centessa Pharmaceuticals
Centessa Pharmaceuticals plc (NASDAQ:CNTA – Free Report) – Equities research analysts at B. Riley lowered their Q1 2025 earnings estimates for shares of Centessa Pharmaceuticals in a research report issued to clients and investors on Thursday, March 27th. B. Riley analyst M. Mamtani now forecasts that the company will earn ($0.38) per share for the […]
